Science & Enterprise subscription

Follow us on Twitter

  • An evaluation of a two year-old home care service for cancer patients shows the program reduces chances of later ho… https://t.co/TupWwuG3ok
    about 17 hours ago
  • New post on Science and Enterprise: Home-Based Cancer Care Boosts Outcomes, Cuts Costs https://t.co/9zcrG432As #Science #Business
    about 17 hours ago
  • Trump: U.S. will terminate relationship with the World Health Organization in wake of Covid-19...… https://t.co/nUXjHixhfe
    about 18 hours ago
  • A company creating a gene therapy for age-related macular degeneration activated with near-infrared rays received a… https://t.co/MOueVM6Nqj
    about 23 hours ago
  • New post on Science and Enterprise: NIH Funds Light-Aided Gene Therapy for Eye Disease https://t.co/CnDzdinH43 #Science #Business
    about 23 hours ago

Please share Science & Enterprise

About Science & Enterprise

Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace. On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.

We get the news to you fast, but we heed the words of legendary UCLA basketball coach John Wooden who said, “Be quick, but don’t hurry.” We want to get it right the first time, but if we err, we own up to our mistakes.

Science and Enterprise is a publication of Technology News and Literature and the creation of veteran Washington, D.C. business, science, and technology writer Alan Kotok.

We look forward to your comments and suggestions: sciencebusiness [at] technewslit [dot] com.

*     *     *